,i #aaf? ,,congress #a/ ,session ,h4 ,r4 #cbbc ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,june #ab1 #bjai ,mr4 ,m>%all 7= himself1 ,mr4 ,wel*1 ,mr4 ,c>t] ( ,georgia1 & ,mr4 ,gonzalez ( ,texas7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to require ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates to /udy ! role ph>macy b5efit manag]s play 9 ! ph>maceutical supply *a9 & to provide ,congress ) appropriate policy recomm5dations1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,ph>macy ,b5efit ,manag] ,acc\ntability ,/udy ,act ( #bjai4 #b4 ,/udy by ,comptroll] ,g5]al ( ,unit$ ,/ates 7a7 ,9 g5]al ,! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all1 9 consultation ) appropriate /akehold]s1 conduct a /udy on ! role ( ph>macy b5efit manag]s ) respect to f$]ally facilitat$ ,ex*anges op]at$ pursuant to section #acba7;c7 ( ! ,pati5t ,protection & ,af=dable ,c>e ,act 7#db ,u4,s4,c4 #ahjda7;c774 7b7 ,p]missible exam9ation ,9 conduct+ ! /udy requir$ "u subsection 7a71 ! ,comptroll] ,g5]al may exam9e v>i\s qualitative & quantitative aspects ( ! role ( ph>macy b5efit manag]s ) respect to f$]ally facilitat$ ,ex*anges describ$ 9 su* subsection1 su* z ! foll[+3 7#a7 ,! role t ph>macy b5efit manag]s play 9 ! ph>maceutical supply *a9 ( su* ,ex*anges4 7#b7 ,! /ate ( competition among ph>macy b5efit manag]s on su* ,ex*anges1 includ+ ! m>ket %>e = ! ,nation's l>ge/ ph>macy b5efit manag]s4 7#c7 ,! use ( rebates & fees by ph>macy b5efit manag]s ) respect to su* ,ex*anges1 includ+-- 7,a7 ! ext5t to :i* rebates are pass$ on to qualifi$ heal? plans (f]$ on su* ,ex*anges & :e!r su* rebates are pass$ on to individuals enroll$ 9 su* plans2 7,b7 ! ext5t to :i* rebates are kept by su* ph>macy b5efit manag]s2 & 7,c7 ! role ( any fees *>g$ by su* ph>macy b5efit manag]s4 7#d7 ,:e!r ph>macy b5efit manag]s /ructure _! =mul>ies ) respect to su* ,ex*anges 9 favor ( high-rebate prescription drugs ov] l[]-co/1 l[]-rebate alt]natives4 7#e7 ,! av]age prior au?orization approval "t = ph>macy b5efit manag]s ) respect to su* ,ex*anges4 7#f7 ,factors affect+ ! use ( /ep !rapy by ph>macy b5efit manag]s ) respect to su* ,ex*anges4 7#g7 ,! ext5t to :i* ! price t ph>macy b5efit manag]s *>ge private payors on su* ,ex*anges = a drug is m ?an su* ph>macy b5efit manag]s pay ! ph>macy = ! drug4 7c7 ,report ,n lat] ?an ! date t is ?ree ye>s aft] ! date ( enactm5t ( ?is ,act1 ! ,comptroll] ,g5]al %all submit to ! ,secret>y ( ,heal? & ,human ,s]vices1 ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate1 & ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives a report conta9+ ! results ( ! /udy conduct$ "u subsection 7a71 includ+ policy recomm5dations4